Report #2836134

Received Apr 15, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Unknown
Age: Age unknown
State: AL
Recovered: Unknown
Vaccinated: Mar 24, 2025
Onset: Mar 24, 2025
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARCEL	VARICELLA (VARIVAX)	MERCK & CO. INC.	UNK	X006981	OT

Symptoms (2)

Expired product administeredNo adverse event

Symptom narrative

No adverse event; HCP called to report that an expired dose of VARIVAX was administered to a patient. VARIVAX expired on 3/7/2025, administered 3/24/2025. Potency of the dose was supported by the Post Expiry Memo. No symptoms reported. Consent to contact is Yes. No a; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions, and concomitant therapies were not reported. On 24-MAR-2025, the patient was vaccinated with an expired dose of Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX), (lot #X006981, expiration date: 07-MAR-2025) 0.5 mL administered by unknown route (exact dose and anatomical location were not provided), which was diluted with a sterile diluent (expiration date and lot # were not reported) as prophylaxis. No symptoms reported (no adverse event).